Anand, D. (2026) “Cardiometabolic Effectiveness and Safety of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk: A Prospective Observational Study”, Adolescência e Saúde, pp. 454–458. doi: 10.67440/ahj.vi.2007.